Matches in Wikidata for { <http://www.wikidata.org/entity/Q64397266> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q64397266 description "clinical trial" @default.
- Q64397266 description "ensayu clínicu" @default.
- Q64397266 description "klinisch onderzoek" @default.
- Q64397266 description "клінічне випробування" @default.
- Q64397266 name "A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)" @default.
- Q64397266 type Item @default.
- Q64397266 label "A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)" @default.
- Q64397266 prefLabel "A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)" @default.
- Q64397266 P1132 Q64397266-357841E3-E866-4CA1-A55B-06258085CEDD @default.
- Q64397266 P1476 Q64397266-9903E86B-6A8F-49E0-A9BA-8E47377CE08C @default.
- Q64397266 P17 Q64397266-22BAC69D-2951-4A5C-B612-BF11CB55C57A @default.
- Q64397266 P17 Q64397266-2E96C630-291F-4F12-A43C-9E7C5BA1F551 @default.
- Q64397266 P17 Q64397266-4F310B32-3409-4ED0-8B57-BD7CC5586B7E @default.
- Q64397266 P17 Q64397266-65994818-E306-41D1-9F0C-7AF767F2FE0B @default.
- Q64397266 P17 Q64397266-7868E80A-0BD2-4401-ADF9-24383BE4CC3B @default.
- Q64397266 P17 Q64397266-A9A59540-774C-46B5-BDC5-EC990C7E84AF @default.
- Q64397266 P17 Q64397266-BBE88D74-D8FE-427B-BA6E-C2BC43CFDC73 @default.
- Q64397266 P17 Q64397266-CFE2CA53-DB9E-4459-BCC5-C3EAED9725B0 @default.
- Q64397266 P17 Q64397266-DD1DF6B0-249B-485F-9F91-5D7D77B5FC6C @default.
- Q64397266 P17 Q64397266-E96A8652-A19A-4CA0-A9EA-56D99ED208EF @default.
- Q64397266 P17 Q64397266-FE8C4385-3F70-4E9B-9D6D-D9E5871F0896 @default.
- Q64397266 P2899 Q64397266-91EE9A4B-475B-4A2C-8576-686CFC4B18F8 @default.
- Q64397266 P3098 Q64397266-6AF5DEE4-3C88-408A-8A3F-A504F38E7179 @default.
- Q64397266 P31 Q64397266-75D206B6-2253-4C74-9A4A-059C64E4D72C @default.
- Q64397266 P4844 Q64397266-37F990DA-9425-4BB6-A298-5503D3584ACC @default.
- Q64397266 P4844 Q64397266-8A77158A-0A27-429E-989F-FA7E44C5692D @default.
- Q64397266 P580 Q64397266-4589F95D-9B0C-4EFC-BEA0-9B0A744A08C7 @default.
- Q64397266 P582 Q64397266-C741EC5D-AAF1-4379-A572-B2A410C09424 @default.
- Q64397266 P6099 Q64397266-26086BFD-5B1F-435D-89DE-A6AAE01713A1 @default.
- Q64397266 P6153 Q64397266-167591E7-3378-438B-80AE-F41ACD8FCE92 @default.
- Q64397266 P6153 Q64397266-22A00FAA-62DD-4DBB-8A99-6AC6C2AE0734 @default.
- Q64397266 P6153 Q64397266-2615E05D-0426-4349-9C0C-FF7444996834 @default.
- Q64397266 P6153 Q64397266-3A502176-1B44-4789-9AD6-2CFB1E732F6E @default.
- Q64397266 P6153 Q64397266-487BD537-6CA2-4BD2-ABFD-DFC600B5FAD7 @default.
- Q64397266 P6153 Q64397266-5BD6C91B-175C-45BD-9306-3D912614450F @default.
- Q64397266 P6153 Q64397266-5C24A2E4-3ADC-4660-A730-6F41D11908E0 @default.
- Q64397266 P6153 Q64397266-6D9F5926-864D-4734-B46D-A983D2DEA337 @default.
- Q64397266 P6153 Q64397266-6DEB2A36-38C6-47CC-BE66-17BBD66A45D4 @default.
- Q64397266 P6153 Q64397266-77E7038C-9382-44B2-A00E-D22C94ADC25E @default.
- Q64397266 P6153 Q64397266-95878625-5D12-4B02-BC35-D862CDCE96CA @default.
- Q64397266 P6153 Q64397266-B3F376F1-4786-4A09-A825-F2EF86ED54BD @default.
- Q64397266 P6153 Q64397266-C0B2D6FA-C2F2-4AEB-B95F-626D6C062D7D @default.
- Q64397266 P8363 Q64397266-F1374091-7DB9-435D-B849-90C5C3CAFC2B @default.
- Q64397266 P859 Q64397266-D4A19BFA-95D7-4A95-8308-8423DC0FF89F @default.
- Q64397266 P1132 "+8" @default.
- Q64397266 P1476 "A Phase III, Open-Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Compared With Gemcitabine+Cisplatin or Carboplatin for PD-L1-Selected, Chemotherapy Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer" @default.
- Q64397266 P17 Q142 @default.
- Q64397266 P17 Q145 @default.
- Q64397266 P17 Q183 @default.
- Q64397266 P17 Q218 @default.
- Q64397266 P17 Q28 @default.
- Q64397266 P17 Q29 @default.
- Q64397266 P17 Q30 @default.
- Q64397266 P17 Q36 @default.
- Q64397266 P17 Q38 @default.
- Q64397266 P17 Q403 @default.
- Q64397266 P17 Q41 @default.
- Q64397266 P2899 "+18" @default.
- Q64397266 P3098 "NCT02409355" @default.
- Q64397266 P31 Q30612 @default.
- Q64397266 P4844 Q412415 @default.
- Q64397266 P4844 Q415588 @default.
- Q64397266 P580 "2015-05-07T00:00:00Z" @default.
- Q64397266 P582 "2017-12-07T00:00:00Z" @default.
- Q64397266 P6099 Q42824827 @default.
- Q64397266 P6153 Q29052 @default.
- Q64397266 P6153 Q30270369 @default.
- Q64397266 P6153 Q30280268 @default.
- Q64397266 P6153 Q333886 @default.
- Q64397266 P6153 Q3803602 @default.
- Q64397266 P6153 Q4916714 @default.
- Q64397266 P6153 Q503415 @default.
- Q64397266 P6153 Q6031854 @default.
- Q64397266 P6153 Q6735870 @default.
- Q64397266 P6153 Q6905066 @default.
- Q64397266 P6153 Q739627 @default.
- Q64397266 P6153 Q7451677 @default.
- Q64397266 P6153 Q89798279 @default.
- Q64397266 P8363 Q78089383 @default.
- Q64397266 P859 Q212646 @default.